Risk Factors for Bisphosphonate-Related Osteonecrosis of the Jaws
β Scribed by Kenneth E. Fleisher; Robert S. Glickman
- Book ID
- 113739363
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 77 KB
- Volume
- 69
- Category
- Article
- ISSN
- 1531-5053
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background Bisphosphonates are known to be associated with osteonecrosis of the jaw. We assess factors underlying the success of surgical treatment in patients with bisphosphonateβrelated osteonecrosis of the jaw (BRONJ). ## Methods Fiftyβeight patients were investigated 6 months
## Abstract ## Background Intravenous bisphosphonate therapy has been used for treatment of benign and malignant bone diseases and has been linked to osteonecrosis of the jaws. ## Methods Records of 638 patients treated with intravenous bisphosphonates were reviewed. Drug used, number of infusio